Recurrence after Different Primary Treatment for Cancer of the Supraglottic Larynx

Authors

  • Halvor Vermund From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Morten Boysen From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Jan F. Evensen From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Anne-Birgitte Jacobsen From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Ketil Natvig From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Johan Tausjo From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Albert L. Wiley From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA
  • Finn Winther From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA

DOI:

https://doi.org/10.1080/028418698429720

Abstract

Retrospective analysis of patient records at two hospitals was performed with the principal goal of clarifying the role of primary radiotherapy in patients with squamous cell carcinoma of the supraglottic larynx. Primary surgery was frequently performed during the first period from 1958 to 1978. Primary radiotherapy with surgery in reserve was the prevailing therapy during the second period from 1978 to 1993. Fewer recurrences were observed during the second period. The improved results were apparent mainly in patients with the more advanced stages (III, T4N0 and T4N1). Analysis of many factors suggest that the more frequent choice of primary radiotherapy with surgery in reserve, or applied as preoperative treatment, with optimal dosage and technique, might have contributed to the improved results.

Downloads

Download data is not yet available.

Author Biography

Jan F. Evensen, From the Norwegian Radium:Rikshospitals, Oslo, Norway and the University of Wisconsin Hospitals, Madison, WI, USA

 

 

Downloads

Published

1998-01-01

How to Cite

Vermund, H. ., Boysen, M. ., Evensen, J. F. ., Jacobsen, A.-B. ., Natvig, K. ., Tausjo, J. ., … Winther, F. . (1998). Recurrence after Different Primary Treatment for Cancer of the Supraglottic Larynx. Acta Oncologica, 37(2), 167–173. https://doi.org/10.1080/028418698429720